To overcome the limitations of autogenous bone, allogeneic bone, and traditional bone substitute materials, a strategy has been developed to achieve bionic mimicry of natural bone from both compositional and structural perspectives. The primary raw materials are HMCOLLAGEN® humanized collagen and hydroxyapatite, which are identical in composition to the extracellular matrix of natural bone. Material design is carried out across multiple scales, including the nanoscale. Through innovative nanobionic processing, a multiscale bionic structure essentially consistent with natural bone is fabricated, enabling the induction and promotion of proliferation and differentiation of osteoprogenitor cells, osteoblasts, and osteoclasts. This accelerates the dynamic balance of bone formation, endowing the material with enhanced bioactivity and osteoinductive repair capacity, thereby providing a superior solution for the field of bone injury regeneration. This product series is currently in the preclinical development stage.